APA način citiranja (7. izdanje)

Gloyn, A., Diatloff-Zito, C., Edghill, E., Bellanné-Chantelot, C., Nivot, S., Coutant, R., . . . Robert, J. (2006). KCNJ11 activating mutations are associated with developmental delay, epilepsy and neonatal diabetes syndrome and other neurological features.

Čikaški stil citiranja (17. izdanje)

Gloyn, A., C. Diatloff-Zito, E. Edghill, C. Bellanné-Chantelot, S. Nivot, R. Coutant, S. Ellard, A. Hattersley, i J. Robert. KCNJ11 Activating Mutations Are Associated with Developmental Delay, Epilepsy and Neonatal Diabetes Syndrome and Other Neurological Features. 2006.

MLA način citiranja (9. izdanje)

Gloyn, A., et al. KCNJ11 Activating Mutations Are Associated with Developmental Delay, Epilepsy and Neonatal Diabetes Syndrome and Other Neurological Features. 2006.